Advanced search
Publication Cover
Current Medical Research and Opinion Volume 32, 2016 - Issue 2
Submit an article Journal homepage
651
Views
6
CrossRef citations to date
0
Altmetric
Original Article

Time on treatment of everolimus and chemotherapy among postmenopausal women with hormone-receptor-positive/human-epidermal-growth-factor-receptor-2-negative metastatic breast cancer: a retrospective claims study in the US

Nanxin LiAnalysis Group Inc., Boston, MA, USACorrespondence[email protected]
,
Yanni HaoNovartis Pharmaceuticals Corporation, East Hanover, NJ, USA
,
Andrew KageleiryAnalysis Group Inc., Boston, MA, USA
,
Miranda PeeplesAnalysis Group Inc., Boston, MA, USA
,
Anna FangAnalysis Group Inc., Boston, MA, USA
,
Valerie KooAnalysis Group Inc., Boston, MA, USA
,
Eric Q. WuAnalysis Group Inc., Boston, MA, USA
&
Annie GuérinAnalysis Group Inc., Montreal, QC, Canada
 show all
Pages 385-394 | Accepted 07 Dec 2015, Published online: 16 Jan 2016

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Derek H. Tang, Nanxin Li, Ella X. Du, Miranda Peeples, Lihao Chu, Jipan Xie & Victoria Barghout. (2017) First-line treatment disruption among post-menopausal women with HR+/HER2– metastatic breast cancer: a retrospective US claims study. Current Medical Research and Opinion 33:12, pages 2137-2143.
Read now
Nanxin Li, Ella X. Du, Lihao Chu, Miranda Peeples, Jipan Xie, Victoria Barghout & Derek H. Tang. (2017) Real-world palbociclib dosing patterns and implications for drug costs in the treatment of HR+/HER2- metastatic breast cancer. Expert Opinion on Pharmacotherapy 18:12, pages 1167-1178.
Read now

Articles from other publishers (4)

Tianyu Li, Tiantao Kuang, Zhaoshuo Yang, Qiqi Zhang, Wen Zhang & Yue Fan. (2021) Co-treatment With Everolimus, an mTOR-Specific Antagonist, or Downregulation of ELK1 Enhances the Sensitivity of Pancreatic Cancer Cells to Genistein. Frontiers in Cell and Developmental Biology 9.
Crossref
Simon Ekman, Frank Griesinger, Paul Baas, David Chao, Christos Chouaid, John C O'Donnell, John R Penrod, Melinda Daumont, Laure Lacoin, Alexia McKenney, Masha Khovratovich, Robin EJ Munro, Isabelle Durand-Zaleski & Søren Paaske Johnsen. (2019) I-O Optimise: a novel multinational real-world research platform in thoracic malignancies. Future Oncology 15:14, pages 1551-1563.
Crossref
Sebastien Dejust, David Morland, Claire Bruna-Muraille, Jean-Christophe Eymard, Gabriel Yazbek, Aude-Marie Savoye & Dimitri Papathanassiou. (2018) Everolimus-induced pulmonary toxicity. Medicine 97:40, pages e12518.
Crossref
Monika Parisi, Corey Pelletier, Dasha Cherepanov & Michael S Broder. (2018) Outcomes research examining treatments, quality of life and costs in HER2 -negative and triple-negative metastatic breast cancer: a systematic literature review . Journal of Comparative Effectiveness Research 7:1, pages 67-83.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.